AhR ligands such as TCDD have long been known to have endocrine-disrupting properties that can contribute to diverse human diseases including obesity and diabetes [1,2,3,4], atherosclerosis [5,6], various cancers [7,8,9,10], and kidney disease [11,12,13]. This evidence concerns the gene AHR and obesity due to melanocortin 4 receptor deficiency.